Pasithea Therapeutics Corp. KTTA

Full chart Compare
Set alert

Price alert · KTTA

All alert types
0.53 USD +0.16 (+44.02%)

At closeNov 3, 2026, 7:58 PM EST

0.50 -0.03 -5.47%

After hours · Nov 3, 7:58 PM ET

0.3477 Day range 0.5344
0.281 52-week range 2.06
YTD
-58.91%
1 year
-35.05%

Revenue & Expenses

Other Income → Expenses: $2.33MExpenses → Gross Loss: $2.21KExpenses → Selling, General & Admin: $4.51MNet Loss → Expenses: $2.17MRevenue → Cost of Revenue: $15.06KOther Income$2.33MNet Loss$2.17MCost of Revenue$17.27KExpenses$4.51MGross Loss$2.21KSelling, General & Admin$4.51MRevenue$15.06K

Latest period ending Dec 31, 2025 · select a line to chart its full history

KTTA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-20.86M-14.25M-15.98M-12.59M-4.51M
-20.43M-13.90M-15.96M-13.94M-2.17M
-2.91-12.69-13.01-11.03-4.20
KTTA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
55.26M6.92M16.33M33.09M52.97M
60.24M16.06M26.12M45.18M53.32M
5.02M1.28M2.72M2.68M1.90M
55.22M14.78M23.40M42.50M51.42M
KTTA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-15.21M-13.92M-12.81M-11.89M-3.17M
11.00K075.20K-2.30M-21.50K
63.52M4.52M-3.73M-3.21M55.93M
11.00K075.20K-107.10K-21.50K
48.34M-9.41M-16.76M-19.81M52.72M